C
BNTX icon

Covestor’s BioNTech BNTX Stock Holding History

Covestor’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-391
Closed -$31K – 2234
2024
Q2 		$31K Sell
391
-24
-6% -$2.19K 0.02% 1034
2024
Q1 		$38K Buy
415
+133
+47% +$12.8K 0.02% 983
2023
Q4 		$30K Sell
282
-10
-3% -$1.01K 0.02% 1047
2023
Q3 		$32K Buy
+292
New +$32.3K 0.02% 950
2022
Q1 		– Sell
-182
Closed -$30.6K – 2119
2021
Q4 		$47K Buy
+182
New +$49.8K 0.07% 573

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Covestor's BNTX Position: Q3 2024 in Review

Covestor sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 391 shares — an estimated $31K sold.

Covestor first reported a position in BNTX in Q4 2021 and held it in 5 quarters. The position peaked at $47K in Q4 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Covestor reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Covestor sold 391 BioNTech shares in Q3 2024, an estimated $31K.
  • Covestor first reported a position in BioNTech in Q4 2021 and held it in 5 quarters.
  • Covestor's BioNTech position peaked at $47K in Q4 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Covestor's 13F filing for Q3 2024, filed 1 Nov 2024.